Holders — by stockHoldings — by fund
Catalio Capital Management, LP
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-09-30 · filed with the SEC up to 45 days after quarter end · CIK 0001958125
$538.3M
disclosed book value
47
positions
9%
largest position share
Positions, as of 2026-09-30
top 47 of 47 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | AVLNAVALYN PHARMACEUTICALS INC | 1.7M | $48.4M | 9% |
| 2 | BMYBRISTOL-MYERS SQUIBB CO | 499,716 | $31.2M | 5.8% |
| 3 | BBIOBRIDGEBIO PHARMA INC | 425,111 | $28.0M | 5.2% |
| 4 | PBLSPARABILIS MEDICINES INC | 824,043 | $26.6M | 4.9% |
| 5 | JNJJOHNSON & JOHNSON | 99,496 | $26.3M | 4.9% |
| 6 | ASNDASCENDIS PHARMA A/S | 101,445 | $23.1M | 4.3% |
| 7 | ARWRARROWHEAD PHARMACEUTICALS IN | 315,247 | $20.6M | 3.8% |
| 8 | SNDXSYNDAX PHARMACEUTICALS INC | 1.0M | $19.2M | 3.6% |
| 9 | DFTXDEFINIUM THERAPEUTICS INC | 497,964 | $19.0M | 3.5% |
| 10 | CELCCELCUITY INC | 230,609 | $18.3M | 3.4% |
| 11 | SEPNSEPTERNA INC | 454,015 | $17.8M | 3.3% |
| 12 | GHGUARDANT HEALTH INC | 92,579 | $16.5M | 3.1% |
| 13 | PTGXPROTAGONIST THERAPEUTICS INC | 112,418 | $15.8M | 2.9% |
| 14 | TXG10X GENOMICS INC | 164,029 | $14.8M | 2.8% |
| 15 | AMLXAMYLYX PHARMACEUTICALS INC | 505,882 | $14.7M | 2.7% |
| 16 | MLYSMINERALYS THERAPEUTICS INC | 583,364 | $14.7M | 2.7% |
| 17 | EWEDWARDS LIFESCIENCES CORP | 161,121 | $13.9M | 2.6% |
| 18 | CRVSCORVUS PHARMACEUTICALS INC | 1.0M | $11.8M | 2.2% |
| 19 | MANEVERADERMICS INC | 95,646 | $11.6M | 2.2% |
| 20 | ENTXENTERA BIO LTD | 3.9M | $11.4M | 2.1% |
| 21 | IRONDISC MEDICINE INC | 172,709 | $11.3M | 2.1% |
| 22 | ODTXODYSSEY THERAPEUTICS INC | 457,839 | $10.2M | 1.9% |
| 23 | FDMT4D MOLECULAR THERAPEUTICS IN | 684,753 | $9.8M | 1.8% |
| 24 | RAREULTRAGENYX PHARMACEUTICAL IN | 601,760 | $9.0M | 1.7% |
| 25 | BMRNBIOMARIN PHARMACEUTICAL INC | 144,971 | $8.7M | 1.6% |
| 26 | ANNXANNEXON INC | 2.0M | $8.4M | 1.6% |
| 27 | RYTMRHYTHM PHARMACEUTICALS INC | 85,614 | $8.2M | 1.5% |
| 28 | GPCRSTRUCTURE THERAPEUTICS INC | 260,109 | $8.1M | 1.5% |
| 29 | NKTRNEKTAR THERAPEUTICS | 126,817 | $7.7M | 1.4% |
| 30 | IMCRIMMUNOCORE HLDGS PLC | 211,985 | $6.4M | 1.2% |
| 31 | COGTCOGENT BIOSCIENCES INC | 167,716 | $5.4M | 1% |
| 32 | KLRAKAILERA THERAPEUTICS INC | 468,750 | $5.4M | 1% |
| 33 | NTRANATERA INC | 12,530 | $5.2M | 1% |
| 34 | GUTSFRACTYL HEALTH INC | 8.8M | $4.8M | 0.9% |
| 35 | KARDKARDIGAN INC | 312,500 | $4.6M | 0.9% |
| 36 | ELDNELEDON PHARMACEUTICALS INC | 1.6M | $4.1M | 0.8% |
| 37 | HTFLHEARTFLOW INC | 74,969 | $3.7M | 0.7% |
| 38 | BBOTBRIDGEBIO ONCOLOGY THERAPEUT | 699,532 | $2.9M | 0.5% |
| 39 | KRSAKORSANA BIOSCIENCES INC | 87,702 | $2.8M | 0.5% |
| 40 | FRNMFREENOME INC | 158,170 | $2.5M | 0.5% |
| 41 | TARAPROTARA THERAPEUTICS INC | 512,287 | $1.6M | 0.3% |
| 42 | KPTIKARYOPHARM THERAPEUTICS INC | 976,191 | $1.2M | 0.2% |
| 43 | HYPRHYPERFINE INC | 1.3M | $1.1M | 0.2% |
| 44 | MGXMETAGENOMI THERAPEUTICS INC | 528,993 | $560,733 | 0.1% |
| 45 | FTHFAETH THERAPEUTICS INC | 14,718 | $437,713 | 0.1% |
| 46 | OMOUTSET MED INC | 107,456 | $322,368 | 0.1% |
| 47 | ADRXADARX PHARMACEUTICALS INC | 11,357 | $226,459 | 0% |
Source: SEC Form 13F-HR, reporting period 2026-09-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.